ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

November 19, 2004

ONS The Largest And Still Growing With 13,000 Members

May 27, 1988

NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution

November 1, 1974

White House Expected To Nominate Nobel Laureate Harold Varmus As NCI Director

March 17, 2010

Sorafenib Targets AML Driven By Mutant FLT3 Gene

February 29, 2008

NCAB Members Flay NIH Proposals To Kill Cancer Program, Strip Board An NCI Of Special Authority

January 25, 1980